Abstract:OBJECTIVE:To investigate the effect of dendritic cells (DCs) pulsed by oligonucleotide containing "un-methylated cytimidine-phosphodiester bond-guanylic acid" motif (CpG ODN) on ovarian carcinoma cells. METHODS:Dendritic cells were isolated form the peripheral monocytes and co-incubated with synthesized CpG2006, CAI125, important epithelial ovarian cancer-associated antigen, or CpG ODN + CA125 for 72 h. Flow cytometry (FC) was used to detect the expression of CD(1alpha), CD(63), CD(86), and human leucocyte antigen-DR (HLA-DR) on the cell surface. ELISA was used to detect the IL-12 level in the supernatant. T cells were obtained from the DCs. The suspensions of different groups of pulsed DCs were co-incubated with T cells. Mixed lymphocyte reaction (MLR) was used to detect the proliferating activity of the T cells. Ovarian carcinoma cells of the line OVCAR-3 were added into the culture fluid of T cells with different effector-target ratios, and then unpulsed DCs, CpG ODN-pulsed DCs, CpG ODN + CA125-pulsed DCs, and CA125-pulsed DCs were added respectively. MTT colorimetry was performed to measure the A values of different wells so as to calculate the killing rate. RESULTS:(1) The expression levels of CD(63), CD(86), and HLA-DR on the membranes of the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were significantly higher than those of the un-pulsed DCs (all P < 0.01), however, there were no significant differences in the expression of CD(1alpha) among different groups (all P > 0.05). (2) The IL-12 levels in the supernatants of the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were significantly higher than those of the unpulsed and CA125-pulsed groups (all P < 0.01). (3) MLR showed that the T cell proliferation rates of the T cells sensitized by the CpG ODN-pulsed DCs and CpG ODN + C125-pulsed DCs were both higher than those of the T cells stimulated by the unpulsed and CA125-pulsed groups when the effector: target ratio was 10:1 (all P < 0.01). (4) The killing rates on OVCAR-3 cells of the CTLs sensitized by CpG ODN + CA125-pulsed DCs at the same effector: target ratios were all higher than those of the CTLs sensitized by the CpG ODN-pulsed DCs, CA125-pulsed DCs, and unpulsed DCs (all P < 0.01), the killing activity of the cytotoxic T lymphocytes (CTLs) sensitized by CpG ODN+CA125-pulsed DCs on the OVCAR-3 cells was shown even when the effector: target ratio was as low as 10:1, and then increased along with the increase of the effector: target ratio to the height of 64.9%. CONCLUSION:Capable of inducing immune cytotoxicity on ovarian carcinoma, DCs sensitized by CpG ODN + CA125 may have a great implication on clinical application.

Study of 96gp dendritic cells loaded with chemotherapy resistant ovarian cancer

The experiment study of anti-ovary cancer by dendritic cells with heat shock protein 96-peptide complexes

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

Leukemia: Derived Heat Shock Protein Gp96-Peptide Complex Contribution to T Cell and Dendritic Cell Activation

Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation.

Antitumor Effect of Dendritic Cell Modified by Gp96-peptide Complex

The anti-leukemia effect of heat shock protein-peptide complex-96

Immunogenicities of Apoptotic Ovarian Cancer Cells Induced by Paclitaxel Combined with Cisplatin

[Cytotoxicity of Dendritic Cells Pulsed by CpG ODN on Ovarian Carcinoma Cells: in Vitro Experiment with Ovarian Carcinoma Cells].

Potent Antitumor Effect Elicited by Gp96-Peptide Complexes Pulsed by Dendritic Cell on Mice of H22 Liver Cancer

Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia to cure advanced ovarian cancer

Effect of Oxaliplatin Plus Dendritic Cell Loaded Tumor Cell Antigen on Inhibiting Growth of Pancreatic Cancer BxPC-3 Cell

An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells

In Vitro Study on Cytotoxicity of T Cells Induced by Dendritic Cells Loaded with 6B11 Anti-Idiotypeminibody to Ovarian Cancer Cell Lines

Experiment study on the treatment of gastric cancer based on dendritic cells in vitro

Experimental study on ovarian cancer immunotherapy by EpCAM activated dendritic cells induce antigen-specific CD8+ cytotoxic T lymphocytes

Exvivo Experiments of Human Ovarian Cancer Ascites-Derived Exosomes Presented by Dendritic Cells Derived from Umbilical Cord Blood for Immunotherapy Treatment

Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer

[Autologous lung cancer tissues derived gp96-peptide complex/dendritic cell vaccine induces the cytotoxic T cell response in vitro].

Effect of gp96 polypeptide complex on maturation and function of dendritic cells

HSPgp96-peptide complexes for anti-tumor immunity of mice with osteosarcoma